• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Dolby Laboratories filed SEC Form 8-K: Results of Operations and Financial Condition

    1/29/26 4:15:11 PM ET
    $DLB
    Multi-Sector Companies
    Miscellaneous
    Get the next $DLB alert in real time by email
    8-K
    false 0001308547 0001308547 2026-01-29 2026-01-29
     
     

    UNITED STATES

    SECURITIES AND EXCHANGE COMMISSION

    Washington, D.C. 20549

     

     

    FORM 8-K

     

     

    CURRENT REPORT

    Pursuant to Section 13 or 15(d)

    of The Securities Exchange Act of 1934

    Date of Report (Date of earliest event reported):

    January 29, 2026

     

     

    DOLBY LABORATORIES, INC.

    (Exact name of registrant as specified in its charter)

     

     

     

    Delaware   001-32431   90-0199783

    (State or other jurisdiction

    of incorporation)

     

    (Commission

    File Number)

     

    (IRS Employer

    Identification No.)

    1275 Market Street

    San Francisco, CA 94103-1410

    (Address of principal executive offices) (Zip Code)

    (415) 558-0200

    (Registrant’s telephone number, including area code)

    Not Applicable

    (Former name or former address, if changed since last report)

     

     

    Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

     

    ☐

    Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

     

    ☐

    Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

     

    ☐

    Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

     

    ☐

    Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

    Securities registered pursuant to Section 12(b) of the Act:

     

    Title of each class

     

    Trading
    Symbol(s)

     

    Name of each exchange
    on which registered

    Class A common stock, $0.001 par value   DLB   The New York Stock Exchange

    Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

    Emerging growth company ☐

    If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

     

     
     


    Section 2 - Financial Information

    ITEM 2.02 Results of Operations and Financial Condition.

    The following information is intended to be furnished under Item 2.02 of Form 8-K, “Results of Operations and Financial Condition.” This information shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as shall be expressly set forth by specific reference in such a filing.

    On January 29, 2026, Dolby Laboratories, Inc. (the “Company”) issued a press release announcing its financial results for its fiscal quarter ended December 26, 2025. The full text of the press release is furnished as Exhibit 99.1 and is incorporated herein by reference.

    Section 8 – Other Events

    ITEM 8.01 Other Events

    Declaration of Dividend

    On January 29, 2026, the Company announced a cash dividend of $0.36 per share of Class A and Class B Common Stock, payable on February 18, 2026 to stockholders of record as of the close of business on February 10, 2026.

    Disclosure Channels to Disseminate Information

    The Company disseminates information to the public about the Company, its products, services and other matters through various channels, including the Company’s website (www.dolby.com), investor relations website (http://investor.dolby.com), SEC filings, press releases, public conference calls and webcasts, in order to achieve broad, non-exclusionary distribution of information to the public. The Company encourages investors and others to review the information it makes public through these channels, as such information could be deemed to be material information.

    Section 9 - Financial Statements and Exhibits

    ITEM 9.01 Financial Statements and Exhibits.

    (d) Exhibits.

     

    Exhibit
    No.

      

    Description

    99.1    Press Release of Dolby Laboratories, Inc. dated January 29, 2026
    104    Cover Page Interactive Data File (embedded within the Inline XBRL document)

     


    SIGNATURES

    Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

     

      DOLBY LABORATORIES, INC.
    By:  

    /s/ Robert Park

     

    Robert Park

    Senior Vice President and Chief Financial Officer (Principal Financial Officer)

    Date: January 29, 2026

    Get the next $DLB alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $DLB

    DatePrice TargetRatingAnalyst
    9/5/2025$74.00Neutral
    Robert W. Baird
    5/15/2025$112.00Buy
    Tigress Financial
    6/3/2024$100.00Mkt Perform → Outperform
    Barrington Research
    11/18/2022Outperform → Mkt Perform
    Barrington Research
    5/24/2022$90.00Buy
    Rosenblatt
    8/2/2021$115.00Mkt Perform → Outperform
    Barrington Research
    More analyst ratings

    $DLB
    SEC Filings

    View All

    SEC Form 10-Q filed by Dolby Laboratories

    10-Q - Dolby Laboratories, Inc. (0001308547) (Filer)

    1/29/26 4:57:43 PM ET
    $DLB
    Multi-Sector Companies
    Miscellaneous

    Dolby Laboratories filed SEC Form 8-K: Results of Operations and Financial Condition

    8-K - Dolby Laboratories, Inc. (0001308547) (Filer)

    1/29/26 4:15:11 PM ET
    $DLB
    Multi-Sector Companies
    Miscellaneous

    SEC Form 144 filed by Dolby Laboratories

    144 - Dolby Laboratories, Inc. (0001308547) (Subject)

    12/17/25 4:10:08 PM ET
    $DLB
    Multi-Sector Companies
    Miscellaneous

    $DLB
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    President and CEO Yeaman Kevin J bought $200 worth of shares (3 units at $78.15) (SEC Form 4)

    4 - Dolby Laboratories, Inc. (0001308547) (Issuer)

    6/25/24 9:28:41 PM ET
    $DLB
    Multi-Sector Companies
    Miscellaneous

    $DLB
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Dolby Laboratories Reports First Quarter 2026 Financial Results

    SAN FRANCISCO, Jan. 29, 2026 /PRNewswire/ -- Dolby Laboratories, Inc. (NYSE:DLB) today announced the company's financial results for the first quarter of fiscal 2026. "With a good start to the fiscal year, we are optimistic about our position in the market and confident in our growth opportunities," said Kevin Yeaman, President and CEO, Dolby Laboratories. "We continue to have strong momentum with Dolby Atmos and Dolby Vision, while also expanding our addressable market with our imaging patent program for content streamers and Dolby OptiView." First Quarter Fiscal 2026 Financi

    1/29/26 4:15:00 PM ET
    $DLB
    Multi-Sector Companies
    Miscellaneous

    Dolby Laboratories Announces Conference Call and Webcast for Q1 Fiscal 2026 Financial Results

    SAN FRANCISCO, Jan. 13, 2026 /PRNewswire/ -- Dolby Laboratories, Inc. (NYSE:DLB), a leader in immersive entertainment experiences, will release financial results for the first quarter (Q1) fiscal year 2026 after the close of regular trading on Thursday, January 29, 2026. Members of Dolby management will lead a conference call open to all interested parties to discuss Q1 fiscal year 2026 financial results for Dolby Laboratories at 2:00 p.m. PT (5:00 p.m. ET) on Thursday, January 29, 2026. Access to the teleconference will be available at http://investor.dolby.com or by dialing

    1/13/26 4:15:00 PM ET
    $DLB
    Multi-Sector Companies
    Miscellaneous

    Dolby Sets the New Standard for Premium Entertainment at CES 2026

    Throughout the week, Dolby brings to life the latest innovations shaping how people watch, listen and enjoy their favorite entertainment LAS VEGAS, Jan. 6, 2026 /PRNewswire/ -- Dolby Laboratories, a leader in immersive entertainment experiences, will spotlight its latest innovations at the 2026 Consumer Electronics Show (CES), demonstrating how Dolby technologies are redefining the way entertainment is created, delivered and experienced. With Dolby, picture quality will become more vibrant and dynamic, in-car entertainment will feel more immersive, and streaming will bring audiences closer to the action than ever before.

    1/6/26 8:30:00 AM ET
    $DLB
    Multi-Sector Companies
    Miscellaneous

    $DLB
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Robert W. Baird initiated coverage on Dolby Labs with a new price target

    Robert W. Baird initiated coverage of Dolby Labs with a rating of Neutral and set a new price target of $74.00

    9/5/25 7:58:56 AM ET
    $DLB
    Multi-Sector Companies
    Miscellaneous

    Tigress Financial resumed coverage on Dolby Labs with a new price target

    Tigress Financial resumed coverage of Dolby Labs with a rating of Buy and set a new price target of $112.00

    5/15/25 9:48:54 AM ET
    $DLB
    Multi-Sector Companies
    Miscellaneous

    Dolby Labs upgraded by Barrington Research with a new price target

    Barrington Research upgraded Dolby Labs from Mkt Perform to Outperform and set a new price target of $100.00

    6/3/24 9:17:02 AM ET
    $DLB
    Multi-Sector Companies
    Miscellaneous

    $DLB
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    SVP, Entertainment Couling John D was granted 25,633 shares, converted options into 6,825 shares and covered exercise/tax liability with 10,815 shares, increasing direct ownership by 20% to 129,708 units (SEC Form 4)

    4 - Dolby Laboratories, Inc. (0001308547) (Issuer)

    12/17/25 9:48:47 PM ET
    $DLB
    Multi-Sector Companies
    Miscellaneous

    VP, CAO and Corp. Controller Nicholson Ryan was granted 9,032 shares and covered exercise/tax liability with 2,184 shares, increasing direct ownership by 23% to 36,956 units (SEC Form 4)

    4 - Dolby Laboratories, Inc. (0001308547) (Issuer)

    12/17/25 9:46:19 PM ET
    $DLB
    Multi-Sector Companies
    Miscellaneous

    SVP, Chief Marketing Officer Pendleton Todd converted options into 5,233 shares, covered exercise/tax liability with 8,015 shares and was granted 18,848 shares, increasing direct ownership by 43% to 53,356 units (SEC Form 4)

    4 - Dolby Laboratories, Inc. (0001308547) (Issuer)

    12/17/25 9:44:30 PM ET
    $DLB
    Multi-Sector Companies
    Miscellaneous

    $DLB
    Financials

    Live finance-specific insights

    View All

    Dolby Laboratories Reports First Quarter 2026 Financial Results

    SAN FRANCISCO, Jan. 29, 2026 /PRNewswire/ -- Dolby Laboratories, Inc. (NYSE:DLB) today announced the company's financial results for the first quarter of fiscal 2026. "With a good start to the fiscal year, we are optimistic about our position in the market and confident in our growth opportunities," said Kevin Yeaman, President and CEO, Dolby Laboratories. "We continue to have strong momentum with Dolby Atmos and Dolby Vision, while also expanding our addressable market with our imaging patent program for content streamers and Dolby OptiView." First Quarter Fiscal 2026 Financi

    1/29/26 4:15:00 PM ET
    $DLB
    Multi-Sector Companies
    Miscellaneous

    Dolby Laboratories Announces Conference Call and Webcast for Q1 Fiscal 2026 Financial Results

    SAN FRANCISCO, Jan. 13, 2026 /PRNewswire/ -- Dolby Laboratories, Inc. (NYSE:DLB), a leader in immersive entertainment experiences, will release financial results for the first quarter (Q1) fiscal year 2026 after the close of regular trading on Thursday, January 29, 2026. Members of Dolby management will lead a conference call open to all interested parties to discuss Q1 fiscal year 2026 financial results for Dolby Laboratories at 2:00 p.m. PT (5:00 p.m. ET) on Thursday, January 29, 2026. Access to the teleconference will be available at http://investor.dolby.com or by dialing

    1/13/26 4:15:00 PM ET
    $DLB
    Multi-Sector Companies
    Miscellaneous

    Dolby Laboratories Reports Fourth Quarter and Fiscal Year 2025 Financial Results

    SAN FRANCISCO, Nov. 18, 2025 /PRNewswire/ -- Dolby Laboratories, Inc. (NYSE:DLB) today announced the company's financial results for the fourth quarter and fiscal year 2025. "We finished FY25 strong, growing Dolby Atmos, Dolby Vision and imaging patents, and expanding our addressable market with momentum in Dolby OptiView and the introduction of a new imaging patent pool for content streamers," said Kevin Yeaman, President and CEO, Dolby Laboratories. "As we head into FY26, I'm confident in our strategy to grow our business by delivering value across current and future ecosyst

    11/18/25 4:15:00 PM ET
    $DLB
    Multi-Sector Companies
    Miscellaneous

    $DLB
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13G/A filed by Dolby Laboratories

    SC 13G/A - Dolby Laboratories, Inc. (0001308547) (Subject)

    11/13/24 4:05:17 PM ET
    $DLB
    Multi-Sector Companies
    Miscellaneous

    Amendment: SEC Form SC 13G/A filed by Dolby Laboratories

    SC 13G/A - Dolby Laboratories, Inc. (0001308547) (Subject)

    9/10/24 4:39:00 PM ET
    $DLB
    Multi-Sector Companies
    Miscellaneous

    SEC Form SC 13G/A filed by Dolby Laboratories (Amendment)

    SC 13G/A - Dolby Laboratories, Inc. (0001308547) (Subject)

    2/13/24 5:02:35 PM ET
    $DLB
    Multi-Sector Companies
    Miscellaneous

    $DLB
    Leadership Updates

    Live Leadership Updates

    View All

    OpenSesame Appoints Tamar Elkeles, PhD, and Emily Rollins to its Board of Directors

    OpenSesame today announced it has appointed Tamar Elkeles, PhD, and Emily Rollins to its Board of Directors. Dr. Elkeles is a highly regarded Chief Human Resources Officer and thought leader, advising globally on Talent, Learning, Human Resources, and Organization Development. Ms. Rollins has served hundreds of companies during her career at Deloitte, where she held various leadership positions in their U.S. Technology, Media, and Telecommunications practice, Audit Innovation and Transformation, and Diversity and Inclusion initiatives. Both executives bring decades of experience in technology, talent, finance, and governance to OpenSesame. Dr. Elkeles has spent 30 years in the human capit

    8/10/22 9:00:00 AM ET
    $DLB
    $GPX
    $SNCE
    Multi-Sector Companies
    Miscellaneous
    Other Consumer Services
    Consumer Services

    Dolby Laboratories Announces Dr. Shriram Revankar as SVP Advanced Technology Group

    SAN FRANCISCO, May 03, 2022 (GLOBE NEWSWIRE) -- Dolby Laboratories, Inc. (NYSE:DLB), a leader in immersive entertainment experiences, today announced the appointment of Dr. Shriram Revankar, a technologist and industry leader who has cultivated teams across multiple disciplines to deliver high impact technologies and world-class research, as its Senior Vice President Advanced Technology Group. Shriram will lead Dolby's global Advanced Technology Group building on the company's decades of innovation. Most recently, as Vice President and Fellow at Adobe, Shriram founded several of Adobe's global research labs, including the Big-Data Experience Lab and the Document Intelligence Lab. Through

    5/3/22 12:00:00 PM ET
    $DLB
    Multi-Sector Companies
    Miscellaneous

    Dolby Appoints Tony Prophet to its Board of Directors

    SAN FRANCISCO, Dec. 08, 2021 (GLOBE NEWSWIRE) -- Dolby Laboratories, Inc. (NYSE:DLB) announced today the appointment of Tony Prophet to its Board of Directors, effective December 6, 2021. Over the course of many years, Tony has established himself as a technology industry leader who has helped guide companies across multiple disciplines. Most recently, Tony served as the Chief Equality and Recruiting Officer at Salesforce, co-chairing the Salesforce Racial Equality and Justice Task Force, created to help drive systemic change in the workplace and community. He was also a co-founder of the company's Ethical and Humane Use of technology initiative. During his time with Microsoft, Tony serve

    12/8/21 8:30:00 AM ET
    $DLB
    Multi-Sector Companies
    Miscellaneous